Outcomes of patients with COVID-19 supported by venovenous extracorporeal membrane oxygenation for greater than 90 daysCentral MessagePerspective

Outcomes of patients with COVID-19 supported by venovenous extracorporeal membrane oxygenation for greater than 90 daysCentral MessagePerspective

Objective: To determine the characteristics and outcomes of patients requiring prolonged (>90 days) venovenous extracorporeal membrane oxygenation (VV ECMO) support for refractory Coronavirus disease 2019 (COVID-19)-associated respiratory failure. Methods: A retrospective, observational analysis...

Full description

Bibliographic Details
Main Authors: David R. Stern, MD, Lauren A. Michalak, PA-C, Allison R. Beckett, MD, Deborah R. Tabachnick, MD, Antone J. Tatooles, MD
Format: Article
Language:English
Published: Elsevier 2023-12-01
Series:JTCVS Open
Subjects:
COVID-19
respiratory failure
ECMO
VV ECMO
prolonged ECMO
Online Access:http://www.sciencedirect.com/science/article/pii/S2666273623003340

Internet

http://www.sciencedirect.com/science/article/pii/S2666273623003340

Similar Items